Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • SuzuBell
    Member
    • Nov 2013
    • 22

    #1

    Pipeline for inferring tissues from liquid biopsy data

    In many cases, solid tissue biopsies cannot be performed in humans. If a liquid biopsy is performed on humans, we can assess microRNA, RNA, and DNA in the blood. These microRNA, RNA, and DNA presumably came from solid tissues. I have read that it can be inferred which tissues these microRNA, RNA, and DNA likely came from.

    If that is true, what is the general pipeline for such an analysis (at a high level, i.e. for a non expert)? Are there any resources for a newbie interested in this type of research to better understand this pipeline?
  • Michael.Ante
    Senior Member
    • Oct 2011
    • 127

    #2
    For solid tissue analysis, you have the assumption, that your observed xNA (miroRNA, RNA, DNA, etc.) is derived from one origin showing a certain 'fingerprint'. Meaning that your observation is depending on the tissue type. In such a case, you can use e.g. biogps.org datasets to perform a GSEA to obtain/rank the tissues which fit best to your data set.

    In your blood or other liquid sample, you have a mixture of xNAs produced in various tissues. The "simple" dependency assumption is not working.
    I fear it's not as easy to trace back from which tissue a certain amount a feature is produced. Especially, since you cannot deduce directly from an observed tissue-related expression/feature that this tissue is able to secrete the xNA into the blood.

    There might be certain microRNAs / RNAs which are only produced in certain tissue(s) exclusively (for instance MUP4 in mouse lacrimal glands).

    You might start with a simple likelihood model for each feature from which tissue it might came from.

    Best,

    Michael

    Comment

    • SuzuBell
      Member
      • Nov 2013
      • 22

      #3
      Thank you for your response. I can certainly write some scripts that use likelihood models to estimate which tissue each feature may be derived from.

      As a confirmation, it seems there are no software or published pipelines already available for inferring which tissues xNA from blood samples are likely derived from?

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
        by SEQadmin2



        CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

        Despite this, “CRISPR helped turn genome editing from a specialized technique into
        ...
        07-31-2026, 11:01 AM
      • SEQadmin2
        Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
        by SEQadmin2


        Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

        The systematic characterization of the human proteome has
        ...
        07-20-2026, 11:48 AM
      • SEQadmin2
        Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
        by SEQadmin2



        Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
        ...
        07-09-2026, 11:10 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, Yesterday, 07:41 AM
      0 responses
      12 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 08-03-2026, 10:13 AM
      0 responses
      25 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-31-2026, 02:55 AM
      0 responses
      39 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-24-2026, 12:17 PM
      0 responses
      25 views
      0 reactions
      Last Post SEQadmin2  
      Working...